NNNN

Anbio Biotechnology

Healthcare · Medical Instruments & Supplies

5.60$ -11.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Income Statement NNNN
Line item	Q2 23	Q4 23	Q2 24	Q4 24	Q2 25	Q3 25	Q1 26
Revenue	0.08	0.09	0.15	0.06	0.11	0.05	0.11
Cost of Revenue	0.03	0.05	0.05	0.01	0.01	0.01	0.02
Gross Profit	0.05	0.04	0.10	0.05	0.11	0.04	0.09
Research & Development	–	0.00	0.00	0.01	0.00	0.00	0.00
Total Operating Expenses	0.01	0.03	0.01	0.09	0.02	0.01	0.02
Operating Income	0.04	0.01	0.09	-0.04	0.08	0.03	0.06
Pre-Tax Income	0.04	0.02	0.09	-0.03	0.09	0.03	0.07
Net Income	0.04	0.02	0.09	-0.03	0.09	0.03	0.07
EBITDA	0.04	0.02	0.09	-0.03	0.08	–	0.06

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.